PMP22 and ovarian carcinoma: We found that the expression of BANF1, CDK2AP2, DDT, LRIG1, MRPL4, and S100A13 was upregulated in ovarian cancer samples, and the expression of EPS8, NUCB2, PAF1, PMP22, RABGAP1L, and USO1 was upregulated in normal samples.